Stockscreener 앱 받기
16.03
2.61%
-0.43
시간 외 거래:
16.03
전일 마감가:
$16.46
열려 있는:
$16.57
하루 거래량:
3.28M
Relative Volume:
1.23
시가총액:
$3.19B
수익:
$3.90B
순이익/손실:
$-413.00M
주가수익비율:
-7.744
EPS:
-2.07
순현금흐름:
$365.00M
1주 성능:
+2.23%
1개월 성능:
+0.19%
6개월 성능:
-17.92%
1년 성능:
-39.35%
1일 변동 폭
$16.01
$16.59
1주일 범위
$15.62
$16.96
52주 변동 폭
$12.16
$27.95
덴츠플라이 Stock (XRAY) Company Profile
명칭
Dentsply Sirona Inc
전화
844-546-3722
주소
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
XRAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
16.03 | 3.28B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
495.86 | 175.16B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.32 | 52.63B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.86 | 45.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
275.16 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
263.51 | 20.05B | 2.90B | 467.20M | 306.90M | 6.37 |
덴츠플라이 Stock (XRAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-01-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | 재확인 | Needham | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-11-16 | 개시 | Needham | Buy |
| 2023-11-10 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | 업그레이드 | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-04-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | 개시 | Morgan Stanley | Overweight |
| 2021-10-01 | 재개 | Credit Suisse | Outperform |
| 2021-08-09 | 재확인 | H.C. Wainwright | Neutral |
| 2021-08-06 | 재확인 | Barrington Research | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-03-02 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | 재확인 | H.C. Wainwright | Neutral |
| 2021-01-05 | 재확인 | H.C. Wainwright | Neutral |
| 2020-12-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-11-17 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-11-09 | 재확인 | H.C. Wainwright | Neutral |
| 2020-10-22 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-08-10 | 재확인 | H.C. Wainwright | Neutral |
| 2020-06-16 | 개시 | Piper Sandler | Overweight |
| 2020-06-15 | 재확인 | H.C. Wainwright | Neutral |
| 2020-05-27 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-05-11 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | 재확인 | H.C. Wainwright | Neutral |
| 2020-04-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-19 | 재확인 | Stifel | Buy |
| 2019-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-08-02 | 업그레이드 | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | 개시 | Evercore ISI | In-line |
| 2019-07-09 | 재확인 | H.C. Wainwright | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
모두보기
덴츠플라이 주식(XRAY)의 최신 뉴스
DENTSPLY SIRONA Inc. Stock Analysis and ForecastAccelerated earnings growth - PrintWeekIndia
What drives DENTSPLY SIRONA Inc. stock priceAccelerated wealth expansion - PrintWeekIndia
Is DENTSPLY SIRONA Inc. a good long term investmentConsistent wealth multiplication - PrintWeekIndia
What analysts say about DENTSPLY SIRONA Inc. stockExplosive wealth accumulation - PrintWeekIndia
Does DENTSPLY SIRONA Inc. stock pay reliable dividendsFree Technical Analysis Support - jammulinksnews.com
What makes DENTSPLY SIRONA Inc. stock attractive to long term investorsTurbocharged investment results - jammulinksnews.com
DENTSPLY SIRONA (NASDAQ:XRAY) adds US$207m to market cap in the past 7 days, though investors from five years ago are still down 59% - Yahoo Finance
Dentsply Sirona (XRAY) Stock Outlook: Analyst Maintains Outperform Rating and $21 Price Target - AInvest
Dentsply Sirona names Daniel Scavilla as new CEO, reaffirms 2025 outlook - MSN
G-III, Tecnoglass, MYR Group, Jabil, and Dentsply Sirona Shares Are Soaring, What You Need To Know - TradingView
Forecasting The Future: 4 Analyst Projections For Dentsply Sirona - Nasdaq
Macro Challenges and Soft Demand Muddy Dentsply's Recovery Plan, but Our Positive Outlook Remains - Morningstar
Globus promotes Keith Pfeil to CEO as former exec leaves for Dentsply - MedTech Dive
Here's Why Dentsply International (XRAY) is a Strong Value Stock - Yahoo Finance
Dental Implants and Prosthetics Market is projected to reach US$ - openPR.com
Dentsply Sirona names Daniel Scavilla as new CEO - Dental Tribune US
Dental Equipment Market is projected to reach US$ 12.4 billion - openPR.com
Dental Burs Market Gains Momentum in Aesthetic Dentistry - openPR.com
DENTSPLY SIRONA's Cautious Outlook Amid Leadership Transition and Limited Growth Potential - AInvest
Globus Medical CEO leaves for Dentsply Sirona corner office - MassDevice
Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know - Yahoo Finance
Equinix, Gevo, Dentsply Sirona - TradingView
Hold Rating on DENTSPLY SIRONA Amid CEO Transition and Mixed Financial Outlook - TipRanks
DENTSPLY SIRONA's Leadership Transition and Strategic Reinvigoration: A Catalyst for Long-Term Value Creation - AInvest
Daniel Scavilla Named CEO of Dentsply Sirona - Dentistry Today
Dentsply Sirona Names New CEO And Beats Expectations - Finimize
Dentsply Sirona Hires Globus CEO Dan Scavilla as Chief Exec - Medical Product Outsourcing
Dentsply Sirona names Daniel Scavilla as new CEO effective August 1 - Investing.com India
Dentsply Sirona Appoints Daniel Scavilla as President and CEO, Effective August 1, 2025 - Quiver Quantitative
Dentsply Sirona appoints new CEO, prelim Q2 revenue beats estimates - TradingView
Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer - GlobeNewswire
Former Globus Medical CEO Takes Helm at Dentsply Sirona as Q2 Sales Hit $935M - Stock Titan
Dentsply Sirona: CEO Transition Doesn't Sway Our Favorable Long-Term Outlook - Morningstar
덴츠플라이 (XRAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
5.59%
자본화:
|
볼륨(24시간):